Milos Dokmanovic BS, PhD

Dr. Milos Dokmanovic is a product quality reviewer for monoclonal antibody-based products in clinical testing and commercial licensure. He joined US Food and Drug Administration, Office of Biotechnology Products, in 2007, as IOTF Fellow and has published research articles on identification of mechanisms of action and therapeutic resistance for monoclonal antibody therapies. Dr. Dokmanovic received his B.Sc. from University of Belgrade in 1996, Ph.D. from University of Illinois at Chicago in 2003 and holds RAC certification since 2013.